Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2005
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1697654A Use of COx-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227245C Food product and producing method
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/16/2005CN1227008C Method of converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
11/16/2005CN1227005C Nimesulide containing topical pharmaceutical compositions
11/16/2005CN1226991C Turmeric as antiirritant in composition contg. hydroxy acid or retinene derives.
11/15/2005US6965039 7-carboxy-flavone derivatives preparation method and therapeutic use
11/15/2005US6965030 MAP kinase inhibitors; treating arthritis, ankylosing spondylitis, psoriatic arthritis, various gastrointestinal disorders; adult respiratory distress syndrome, asthma, COPD and Alzheimer's disease.
11/15/2005US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964981 Therapeutic treatment or prevention of physiological disorders associated with an excess of tachykinins, with neurokinin 1 (NK-1) receptor antagonists; a 2-phenyl-2-(3-phenyl-tetrahydrofuran-2-yloxy)- ethanol
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964975 Isoxazole and thiazole compounds and use thereof as medicine
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105804A1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105102A1 Improved nsaid composition
11/10/2005US20050251289 Medicament dispenser
11/10/2005US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives
11/10/2005US20050250881 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250780 Piperimido[1,2-a]piperazine-4,7diones derivatives; neurokinin (tachykinin) receptor antagonists; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; analgesic, neurodegenerative disorders, respiratory diseases, antiinflammatory agent, antidepressant
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250730 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050249783 Method of improving absorption of vitamin e by a pet animal
11/10/2005US20050249715 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
11/10/2005US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
11/10/2005DE10112926B4 Verwendung von Aminooxyacetat zur Tumorbehandlung Use of aminooxyacetate for tumor treatment
11/10/2005CA2607113A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005CA2565941A1 Improved nsaid composition
11/10/2005CA2564589A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564587A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564277A1 7h-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2563669A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
11/10/2005CA2563454A1 Crth2 receptor antagonists
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592678A1 3-phenylfuran-2-one derivatives as cox-2 inhibitor
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1592666A1 2,3 -bipyridines derivatives as selective cox-2 inhibitors
11/09/2005EP1592426A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/09/2005EP1592418A2 Use in therapy of endocannabinoid-like compounds
11/09/2005EP1592414A1 Injectable liquid formulation of paracetamol
11/09/2005EP1592402A2 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
11/09/2005EP1592387A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592386A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1423378B1 Aminopyrrole compounds as antiinflammatory agents
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1297172B1 Methods for producing modified glycoproteins
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1218366B8 Method for producing cox-2 inhibitors
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 1272